J1576 HCPCS Level II code: Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1576 is the HCPCS code for “Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
Short description: Inj, panzyga, 500 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J1576 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2023
Where J1576 sits
- 1J codesDrugs administered other than orally
- 2Active code J1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1576 mean?
J1576 is the HCPCS code for “Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1576?
CMS lists J1576’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1576
All J codesJ1570Injection, ganciclovir sodium, 500 mgJ1571Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 mlJ1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mgJ1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 mlJ1574Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mgJ1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulinJ1577Injection, immune globulin (qivigy), 100 mgJ1580Injection, garamycin, gentamicin, up to 80 mgJ1590Injection, gatifloxacin, 10 mgJ1595Injection, glatiramer acetate, 20 mgJ1596Injection, glycopyrrolate, 0.1 mgJ1597Injection, glycopyrrolate (glyrx-pf), 0.1 mg